Milligan S R, Finn C A
Department of Physiology, King's College, London, UK.
J Reprod Fertil. 1990 Jan;88(1):105-12. doi: 10.1530/jrf.0.0880105.
The possible role of platelet-activating factor (PAF) in the uterine responses associated with implantation was investigated. Attempts to trigger a decidual cell response in the uteri of hormonally sensitized, ovariectomized mice by instilling PAF-acether (1-1000 ng) intraluminally were unsuccessful. The effect of PAF antagonists on implantation was investigated in females ovariectomized on Day 3 of pregnancy and treated with progesterone. Implantation was induced in these females by injection of 10 ng oestradiol-17 beta on Day 8. Hourly intraperitoneal injections of three PAF antagonists (WEB 2086, CV 3988 and BN 52021 at doses of 1.2-1.4 mg/kg) given over a 24-h period starting 1 h before the injection of oestradiol-17 beta had no significant effect on the occurrence of implantation sites. Intraluminal injection of WEB 2086 (15 micrograms) or BN 52021 (5 micrograms) either 3 h before or 6 h after the nidatory oestradiol also had no significant inhibitory effect on implantation. SRI 63-441 given once daily over the first 4 days of pregnancy at a dose of 40 micrograms/30 g body weight had no inhibitory effect on the establishment of pregnancy. These results are not consistent with a critical role for PAF in implantation in mice.
研究了血小板活化因子(PAF)在与着床相关的子宫反应中的可能作用。通过向激素致敏的去卵巢小鼠子宫腔内注入PAF-乙醚(1-1000纳克)来引发蜕膜细胞反应的尝试未成功。在妊娠第3天进行去卵巢并接受孕酮治疗的雌性小鼠中,研究了PAF拮抗剂对着床的影响。在第8天给这些雌性小鼠注射10纳克雌二醇-17β以诱导着床。在注射雌二醇-17β前1小时开始的24小时内,每小时腹腔注射三种PAF拮抗剂(WEB 2086、CV 3988和BN 52021,剂量为1.2-1.4毫克/千克),对着床部位的出现没有显著影响。在着床雌二醇注射前3小时或注射后6小时向子宫腔内注射WEB 2086(15微克)或BN 52021(5微克),对着床也没有显著抑制作用。在妊娠的前4天,以40微克/30克体重的剂量每天一次给予SRI 63-441,对妊娠的建立没有抑制作用。这些结果与PAF在小鼠着床中起关键作用不一致。